BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Grasp Cancer - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://graspcancer.org
X-WR-CALDESC:Events for Grasp Cancer
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Winnipeg
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20260308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20261101T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T180000
DTEND;TZID=America/New_York:20251217T193000
DTSTAMP:20260502T125335
CREATED:20251125T150509Z
LAST-MODIFIED:20260409T150350Z
UID:10000225-1765994400-1765999800@graspcancer.org
SUMMARY:SABCS25 - Group 3B: Early Stage Breast Cancer; Liquid Biopsy
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS2-09-18: Real-time liquid biopsy assessment in early-stage breast cancer: methylation based-ctDNA analysis and CTCs detection as potential predictors of response to neoadjuvant therapy \nPoster #PS2-09-20: Circulating Tumor DNA Dynamics and Anatomical Patterns of Relapse Following Curative Therapy in Early-Stage Breast Cancer
URL:https://graspcancer.org/event/sabcs25-group3b/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group3b/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T180000
DTEND;TZID=America/New_York:20251217T193000
DTSTAMP:20260502T125335
CREATED:20251125T150010Z
LAST-MODIFIED:20260409T150405Z
UID:10000190-1765994400-1765999800@graspcancer.org
SUMMARY:SABCS25 - Group 3A: BEGINNER TRACK: Metastatic Breast Cancer; Side Effects; Symptom Management
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \nThese beginner tracks offer added explanations at a relaxed pace\, ideal for new advocates and anyone who prefers additional clarity. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS1-04-15: A focused evaluation of young adults living with metastatic breast cancer: Patient-reported strategies to alleviate disease symptoms\, treatment-related side effects\, and survivorship concerns \nPoster #PS1-02-22: Delayed Palliative Care in Metastatic Breast Cancer: Rationale for Early Integration
URL:https://graspcancer.org/event/sabcs25-group3a/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group3a/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T140000
DTEND;TZID=America/New_York:20251217T153000
DTSTAMP:20260502T125335
CREATED:20251210T214558Z
LAST-MODIFIED:20260409T150005Z
UID:10000226-1765980000-1765985400@graspcancer.org
SUMMARY:SABCS25 - 🇧🇷 Group 2G: Saúde sexual na sobrevivência ao câncer; Retorno ao trabalho
DESCRIPTION:  \nSan Antonio Breast Cancer Symposium (SABCS)\, a maior conferência de pesquisa em câncer de mama do mundo\, se torna ainda mais especial com as discussões do GRASP\, que reúne pacientes e cientistas em pequenos grupos para conversar sobre os estudos apresentados na conferência. \nInscreva-se abaixo \nEste grupo do GRASP Poster Walkthrough vai explorar resultados essenciais dos seguintes pôsteres: \nPôster #PS1-01-25: Vamos falar sobre sexualidade no cuidado oncológico: uma análise transversal de um programa multicêntrico de sobrevivência \nPôster #PS1-01-28: Traçando o caminho de volta ao trabalho: uma análise transversal de um programa multicêntrico de sobrevivência
URL:https://graspcancer.org/event/sabcs25-group2g/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group2g/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T140000
DTEND;TZID=America/New_York:20251217T153000
DTSTAMP:20260502T125335
CREATED:20251125T142511Z
LAST-MODIFIED:20260409T150022Z
UID:10000204-1765980000-1765985400@graspcancer.org
SUMMARY:SABCS25 - Group 2E: Metastatic Breast Cancer; Brain Metastasis Risk Prediction
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \nPrefer a different time? These same posters will be discussed in another session. Click to join Group 1C instead. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS5-01-08: Development of the HER2DX Predictor of Brain Metastasis in Advanced HER2-Positive Breast Cancer Treated with First-Line THP \nPoster #PS2-08-05: Multimodal integration of real world genomic and clinical data for the prediction of brain metastasis development in breast cancer
URL:https://graspcancer.org/event/sabcs25-group2e/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group2e/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T140000
DTEND;TZID=America/New_York:20251217T153000
DTSTAMP:20260502T125335
CREATED:20251125T142011Z
LAST-MODIFIED:20260409T150042Z
UID:10000203-1765980000-1765985400@graspcancer.org
SUMMARY:SABCS25 - Group 2D: HR+ Metastatic Breast Cancer; ESR1 Mutations; Targeted Therapies; Treatment Resistance
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS1-07-11: Vepdegestrant Overcomes Endocrine and CDK4/6i Resistance to Enhance Radiosensitivity in ESR1 mutant ER+ Breast Cancer \nPoster #PS2-02-04: Real-world treatment patterns and clinical outcomes in patients with emerging estrogen receptor 1 (ESR1)-mutated ER+ metastatic breast cancer in the U.S.\, 2018-2024
URL:https://graspcancer.org/event/sabcs25-group2d/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group2d/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T140000
DTEND;TZID=America/New_York:20251217T153000
DTSTAMP:20260502T125335
CREATED:20251125T141512Z
LAST-MODIFIED:20260409T150103Z
UID:10000202-1765980000-1765985400@graspcancer.org
SUMMARY:SABCS25 - Group 2C: HER2-negative Metastatic Breast Cancer; Tumor Immune Microenvironment
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS3-12-27: Comparative analysis of the tumor immune microenvironment (TIME) and primary and metastatic tissue in HR+/HER2- and triple-negative breast cancer (TNBC) \nPoster #PS3-13-16: Cancer systems immunology unravels complexity of reversing immune suppression and predicts beyond RECIST in metastatic breast cancer
URL:https://graspcancer.org/event/sabcs25-group2c/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group2c/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T140000
DTEND;TZID=America/New_York:20251217T153000
DTSTAMP:20260502T125335
CREATED:20251125T140512Z
LAST-MODIFIED:20260409T150123Z
UID:10000201-1765980000-1765985400@graspcancer.org
SUMMARY:SABCS25 - Group 2B: Lobular Breast Cancer; Disease Monitoring; Liquid Biopsy
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS2-09-04: Predicting outcomes for patients with mixed ductal/lobular carcinoma of the breast based on circulating tumor DNA positivity patterns \nPoster #PS2-07-22: Serial\, multi-omic\, multi-analyte\, liquid biopsy monitoring of metastatic lobular breast cancer to detect clinically-relevant heterogeneity and evolution
URL:https://graspcancer.org/event/sabcs25-group2b/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group2b/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T140000
DTEND;TZID=America/New_York:20251217T153000
DTSTAMP:20260502T125335
CREATED:20251125T140013Z
LAST-MODIFIED:20260409T150138Z
UID:10000187-1765980000-1765985400@graspcancer.org
SUMMARY:SABCS25 - Group 2A: BEGINNER TRACK: Racial and Health Disparities; Side Effects; Symptom Management
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \nThese beginner tracks offer added explanations at a relaxed pace\, ideal for new advocates and anyone who prefers additional clarity. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS1-01-06: Patient-reported measures of taxane-induced peripheral neuropathy (TIPN) and risk of dose reductions or worsening quality of life in Black women with breast cancer: analysis from ECOG-ACRIN EAZ171 \nPoster #PS3-01-22: Targeting Disparities: Impact of Mammographic Screening and Social Drivers on Advanced-Stage Triple-Negative Breast Cancer in Vulnerable Populations Across US Counties
URL:https://graspcancer.org/event/sabcs25-group2a/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group2a/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T100000
DTEND;TZID=America/New_York:20251217T113000
DTSTAMP:20260502T125335
CREATED:20251125T133013Z
LAST-MODIFIED:20260409T141435Z
UID:10000200-1765965600-1765971000@graspcancer.org
SUMMARY:SABCS25 - 🇧🇷 Group 1G: Câncer de mama de início precoce; Sobrevivência e imagem corporal
DESCRIPTION:  \nSan Antonio Breast Cancer Symposium (SABCS)\, a maior conferência de pesquisa em câncer de mama do mundo\, se torna ainda mais especial com as discussões do GRASP\, que reúne pacientes e cientistas em pequenos grupos para conversar sobre os estudos apresentados na conferência. \nInscreva-se abaixo \nEste grupo do GRASP Poster Walkthrough vai explorar resultados essenciais dos seguintes pôsteres: \nPôster #PS5-05-29: Impacto a longo prazo do câncer de mama de início precoce em mulheres brasileiras \nPôster #PS5-12-27: Impacto da simetrização contralateral imediata na satisfação corporal entre sobreviventes no Brasil \n 
URL:https://graspcancer.org/event/sabcs25-group1g/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group1g/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T100000
DTEND;TZID=America/New_York:20251217T113000
DTSTAMP:20260502T125335
CREATED:20251125T132014Z
LAST-MODIFIED:20260409T141803Z
UID:10000197-1765965600-1765971000@graspcancer.org
SUMMARY:SABCS25 - Group 1E: Triple Negative Metastatic Breast Cancer; Antibody-drug Conjugates; Liquid Biopsy
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS5-02-29: Clinical data of DB-1305/BNT325 (TROP2 antibody-drug conjugate [ADC]) in patients (pts) with metastatic triple negative breast cancer (mTNBC): Efficacy and safety data from a phase 1/2 trial \nPoster #PS5-07-09: A randomized clinical trial comparing ctDNA-directed therapy change with standard of care in patients with metastatic triple negative breast cancer (mTNBC)
URL:https://graspcancer.org/event/sabcs25-group1e/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group1e/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T100000
DTEND;TZID=America/New_York:20251217T113000
DTSTAMP:20260502T125335
CREATED:20251125T131514Z
LAST-MODIFIED:20260409T141815Z
UID:10000196-1765965600-1765971000@graspcancer.org
SUMMARY:SABCS25 - Group 1D: Metastatic Breast Cancer; Liquid Biopsy
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS2-07-24: Circulating tumor DNA (ctDNA) biomarker analyses of a phase 1/2 study evaluating vepdegestrant\, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader\, in ER-positive/human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer (aBC) \nPoster #PS4-03-10: Assessing the impact of real-time serial circulating tumor cell results on the management of patients with metastatic breast cancer
URL:https://graspcancer.org/event/sabcs25-group1d/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group1d/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T100000
DTEND;TZID=America/New_York:20251217T113000
DTSTAMP:20260502T125335
CREATED:20251125T131015Z
LAST-MODIFIED:20260409T141328Z
UID:10000195-1765965600-1765971000@graspcancer.org
SUMMARY:SABCS25 - Group 1C: Metastatic Breast Cancer; Brain Metastasis Risk Prediction
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \nPrefer a different time? These same posters will be discussed in another session. Click to join Group 2E instead. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS5-01-08: Development of the HER2DX Predictor of Brain Metastasis in Advanced HER2-Positive Breast Cancer Treated with First-Line THP \nPoster #PS2-08-05: Multimodal integration of real world genomic and clinical data for the prediction of brain metastasis development in breast cancer \n 
URL:https://graspcancer.org/event/sabcs25-group1c/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group1c/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251217T100000
DTEND;TZID=America/New_York:20251217T113000
DTSTAMP:20260502T125335
CREATED:20251125T130515Z
LAST-MODIFIED:20260409T141352Z
UID:10000194-1765965600-1765971000@graspcancer.org
SUMMARY:SABCS25 - Group 1B: Early Stage HER2+ Breast Cancer; Targeted Therapies
DESCRIPTION:  \nThe 2025 San Antonio Breast Cancer Symposium (SABCS) is a global meeting that highlights clinical\, translational\, and basic breast cancer research. It’s a unique opportunity for advocates to join the conversation. \n\nRegister Below\nThis SABCS25 Poster Walkthrough group will explore key findings from the following posters: \nPoster #PS3-11-28: EmpowHER-208: A phase 2 neoadjuvant study of zanidatamab in combination with chemotherapy in patients with stage II-III HER2-positive early breast cancer \nPoster #PS3-08-27: Repower: a real-world noninterventional study of outcomes and experiences in patients with hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) early breast cancer (EBC) treated with an adjuvant cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) plus endocrine therapy (ET)
URL:https://graspcancer.org/event/sabcs25-group1b/
CATEGORIES:Poster Walkthrough
LOCATION:https://graspcancer.org/event/sabcs25-group1b/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Winnipeg:20251209T183000
DTEND;TZID=America/Winnipeg:20251209T203000
DTSTAMP:20260502T125335
CREATED:20251002T155304Z
LAST-MODIFIED:20251209T234807Z
UID:10000168-1765305000-1765312200@graspcancer.org
SUMMARY:GRASP Reception at SABCS25
DESCRIPTION:Attending the 2025 San Antonio Breast Cancer Symposium (SABCS) in person? \nJoin GRASP for our annual reception on Tuesday\, December 9\, from 6:30-8:30pm CT*\, on Terrace Level 3 of the Henry B. Gonzales Convention Center. \nThis tradition at SABCS brings together advocates\, scientists\, and partners to connect and mingle in person outside of formal sessions. \nRefreshments and light fare will be provided. \n*Note: Time listed is Central Standard Time (local in San Antonio time).
URL:https://graspcancer.org/event/sabcs25-reception/
LOCATION:Henry B. Gonzales Convention Center\, 900 E Market St\, San Antonio\, TX\, 78205\, United States
CATEGORIES:Reception
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240827T110000
DTEND;TZID=America/New_York:20240827T120000
DTSTAMP:20260502T125335
CREATED:20251126T133232Z
LAST-MODIFIED:20251126T133232Z
UID:10000091-1724756400-1724760000@graspcancer.org
SUMMARY:Link between Immune Cells and HR+/HER2- Breast Cancer
DESCRIPTION:Dr. Gaia Griguolo will discuss her research and review the poster “Association of tumor-infiltrating lymphocytes (TILs) and immune signatures with PAM50 intrinsic subtyping hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (BC): A translational analysis of two multicentric neoadjuvant trial” which was presented at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO). This session will explore findings from two neoadjuvant trials\, focusing on how the addition of immunotherapy to chemotherapy can benefit high-risk patients. Join us to review the poster and engage in a discussion on these important findings.\n 
URL:https://graspcancer.org/event/link-between-immune-cells-and-hr-her2-breast-cancer/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240822T100000
DTEND;TZID=America/New_York:20240822T110000
DTSTAMP:20260502T125335
CREATED:20251126T133232Z
LAST-MODIFIED:20251126T133232Z
UID:10000094-1724320800-1724324400@graspcancer.org
SUMMARY:OPERA-01: Palazestrant vs. Standard-of-Care for ER+/HER2- MBC
DESCRIPTION:Elisabeth de Kermadec will discuss the OPERA-01 phase 3 study\, focusing on the efficacy of palazestrant (OP-1250) compared to standard treatments in ER+\, HER2- metastatic breast cancer post endocrine therapy and CDK4/6 inhibitor resistance. We will discuss her study and review the poster “the OPERA-01 phase 3 study with us\, focusing on the efficacy of palazestrant (OP-1250) compared to standard treatments in ER+\, HER2- metastatic breast cancer post endocrine therapy and CDK4/6 inhibitor resistance.” which was presented at the 2024 American Society of Clinical Oncology Annual Meeting (ASCO).\n 
URL:https://graspcancer.org/event/opera-01-palazestrant-vs-standard-of-care-for-er-her2-mbc/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240806T120000
DTEND;TZID=America/New_York:20240806T130000
DTSTAMP:20260502T125335
CREATED:20251126T133232Z
LAST-MODIFIED:20251126T133232Z
UID:10000093-1722945600-1722949200@graspcancer.org
SUMMARY:Plant-Based Diet and Exercise Therapy in HR+ Breast Cancer
DESCRIPTION:Dr. Shoshana Rosenberg will review poster “Effects of plant-based diet (PBD) and exercise therapy (Ex) on weight and body composition in patients with primary hormone receptor (HR) positive breast cancer: A phase 2 randomized controlled trial.” This study explores how a personalized energy-restricted PBD combined with exercise can impact weight and body composition in patients with HR-positive breast cancer\, aiming to improve clinical outcomes by addressing obesity-related risks.\n 
URL:https://graspcancer.org/event/plant-based-diet-and-exercise-therapy-in-hr-breast-cancer/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240801T100000
DTEND;TZID=America/New_York:20240801T110000
DTSTAMP:20260502T125335
CREATED:20251126T133233Z
LAST-MODIFIED:20251126T133233Z
UID:10000092-1722506400-1722510000@graspcancer.org
SUMMARY:Decentralized Biobanking: A New Community Engagement Platform
DESCRIPTION:Dr. Marielle Gross will discuss Decentralized Biobanking\, AKA “de-bi\,” a new community engagement platform for patients to track their donated biosamples\, receive personalized research updates\, and engage with scientists in a privacy-preserving network. We will share details about our first de-bi pilot\, launched in 2023 for a large breast cancer biobank. Next\, we will take you on a live tour of the latest de-bi app\, that breaks new ground in uniting patients\, physicians\, and scientists across the country for ongoing collaboration in ovarian cancer research. Join us to learn about the next-generation technology that will revolutionize community research engagement\, and share your input to help maximize de-bi’s accessibility and inclusiveness for all patients who desire a “digital seat at the table.”\n 
URL:https://graspcancer.org/event/decentralized-biobanking-a-new-community-engagement-platform/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240612T100000
DTEND;TZID=America/New_York:20240613T193000
DTSTAMP:20260502T125335
CREATED:20251126T133234Z
LAST-MODIFIED:20251126T133234Z
UID:10000096-1718186400-1718307000@graspcancer.org
SUMMARY:American Society of Clinical Oncology (ASCO24) Annual Meeting
DESCRIPTION:GRASP will be held in conjunction with the 2025 American Society of Clinical Oncology (ASCO) annual meeting which is attended by more than 40\,000 oncology professionals from around the world to discuss the latest advancements in cancer care treatments. GRASP sessions will be held after the conference on June 12-13\, 2024.\nGRASP brings scientists and patient advocates together for a personalized discussion about a scientific poster. Less like a presentation\, and more like a conversation\, advocates are encouraged to share their experiences as people living with or caring for someone with this disease. GRASP scientists serve as “interpreters” using their expertise to effectively communicate complex scientific concepts to a general audience. Patient advocate registration for ASCO24 is free for those interested in participating online.\nGRASP REGISTRATION CLOSED
URL:https://graspcancer.org/event/american-society-of-clinical-oncology-asco24-annual-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240508T110000
DTEND;TZID=America/New_York:20240508T120000
DTSTAMP:20260502T125335
CREATED:20251126T133234Z
LAST-MODIFIED:20251126T133234Z
UID:10000097-1715166000-1715169600@graspcancer.org
SUMMARY:The Final Gift Program: Advancing Cancer Research Through Tissue Donation
DESCRIPTION:Join Dr. Rachel Dittmar\, Ph.D.\, as she discusses the Final Gift Program\,  a tissue donation initiative at MD Anderson Cancer Center. This program enables patients with metastatic breast cancer to make a profound impact on research by donating tissue after their passing\, allowing scientists to better understand the disease at its most advanced stages. Learn more about this unique opportunity for the metastatic community to contribute to groundbreaking cancer research.\n 
URL:https://graspcancer.org/event/the-final-gift-program-advancing-cancer-research-through-tissue-donation/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240424T110000
DTEND;TZID=America/New_York:20240424T120000
DTSTAMP:20260502T125335
CREATED:20251126T133234Z
LAST-MODIFIED:20251126T133234Z
UID:10000099-1713956400-1713960000@graspcancer.org
SUMMARY:Luminate Medical: Chemotherapy Product Design Feedback
DESCRIPTION:Join us for a special Huddle featuring Luminate Medical\, a medical device company based in Ireland\, focused on improving the quality of life for patients undergoing chemotherapy. Luminate Medical is seeking feedback from individuals who have experienced chemotherapy\, past or present\, to provide valuable insights on their innovative product designs aimed at addressing hair loss and peripheral neuropathy. In this informal\, one-hour virtual session\, participants will have the opportunity to share their opinions on the product designs and discuss potential improvements. Your input can help shape the future of these patient-centered solutions!\n 
URL:https://graspcancer.org/event/luminate-medical-chemotherapy-product-design-feedback/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240322T110000
DTEND;TZID=America/New_York:20240322T120000
DTSTAMP:20260502T125335
CREATED:20251126T133235Z
LAST-MODIFIED:20251126T133235Z
UID:10000100-1711105200-1711108800@graspcancer.org
SUMMARY:Luminate Medical: Chemotherapy Product Design Feedback
DESCRIPTION:Join us for a special Huddle featuring Luminate Medical\, a medical device company based in Ireland\, focused on improving the quality of life for patients undergoing chemotherapy. Luminate Medical is seeking feedback from individuals who have experienced chemotherapy\, past or present\, to provide valuable insights on their innovative product designs aimed at addressing hair loss and peripheral neuropathy. In this informal\, one-hour virtual session\, participants will have the opportunity to share their opinions on the product designs and discuss potential improvements. Your input can help shape the future of these patient-centered solutions!\n 
URL:https://graspcancer.org/event/luminate-medical-chemotherapy-product-design-feedback-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240221T180000
DTEND;TZID=America/New_York:20240221T193000
DTSTAMP:20260502T125335
CREATED:20251126T133235Z
LAST-MODIFIED:20251126T133235Z
UID:10000102-1708538400-1708543800@graspcancer.org
SUMMARY:Reception at ASCL24
DESCRIPTION:GRASP / ASCL Reception for advocates and scientists\nScientists: Meet the people whose lives are impacted by your work.\nPatient advocates: Meet the people who dedicate their careers to improving and extending your lives.\nAdvancing the Science of Cancer in Latinos scientists whose posters are being discussed by GRASP and advocates are invited to attend a special reception for scientists and advocates.\nThe event will take place on-site at the Marriott Riverwalk (conference hotel) on Wednesday\, February 21\, in the River Terrace Room and Patio from 6 – 7:30 pm CT. Refreshments and light fare will be provided.\n 
URL:https://graspcancer.org/event/reception-at-ascl24/
CATEGORIES:Reception
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231220T100000
DTEND;TZID=America/New_York:20231220T110000
DTSTAMP:20260502T125335
CREATED:20251126T133235Z
LAST-MODIFIED:20251126T133235Z
UID:10000104-1703066400-1703070000@graspcancer.org
SUMMARY:Exploring Tissue Donation for Metastatic Breast Cancer Research
DESCRIPTION:Join Gitte Zels\, a PhD student and Resident in Anatomic Pathology at KU Leuven\, as she discusses her ILC23 poster titled “Overview of patients with invasive lobular breast carcinoma included in the post-mortem tissue donation program\, UPTIDER.” The discussion will focus on the role of tumor heterogeneity in metastatic breast cancer\, particularly in invasive lobular breast cancer (ILC). She will introduce the post-mortem tissue donation program led by the Laboratory for Translational Breast Cancer Research in Belgium\, highlighting its importance in advancing cancer research and providing insights into the complexities of metastatic disease. The session will provide an overview of the program’s procedures and aims to spark a dynamic conversation with patient advocates.\n 
URL:https://graspcancer.org/event/exploring-tissue-donation-for-metastatic-breast-cancer-research/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231214T100000
DTEND;TZID=America/New_York:20231215T193000
DTSTAMP:20260502T125335
CREATED:20251126T133236Z
LAST-MODIFIED:20251126T133236Z
UID:10000114-1702548000-1702668600@graspcancer.org
SUMMARY:San Antonio Breast Cancer Symposium (SABCS23)
DESCRIPTION:The 2023 San Antonio Breast Cancer Symposium (SABCS) will be held on December 5-9\, 2023. This year’s SABCS conference will be held as a hybrid conference with both in-person events and live web streaming. The Symposium aims to achieve a balance of clinical\, translational\, and basic research\, providing a forum for interaction\, communication\, and education for a broad spectrum of researchers\, health professionals\, and those with a special interest in breast cancer.  GRASP is partnering with SABCS23 to bring our signature Poster Walkthrough program which will be held virtually after the conference on Dec 14-15\, 2023. Registration for the SABCS conference is free for patient advocates.\nGRASP REGISTRATION CLOSED
URL:https://graspcancer.org/event/san-antonio-breast-cancer-symposium-sabcs23/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231212T190000
DTEND;TZID=America/New_York:20231212T200000
DTSTAMP:20260502T125335
CREATED:20251126T133236Z
LAST-MODIFIED:20251126T133236Z
UID:10000116-1702407600-1702411200@graspcancer.org
SUMMARY:GRASP Training III
DESCRIPTION:Join us for a training session so that you can be prepared for your upcoming event. Whether joining as a GRASP scientist\, poster author\, mentor\, or patient advocate\, these sessions will help you understand your respective role.
URL:https://graspcancer.org/event/grasp-training-iii/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231201T110000
DTEND;TZID=America/New_York:20231201T120000
DTSTAMP:20260502T125335
CREATED:20251126T133237Z
LAST-MODIFIED:20251126T133237Z
UID:10000120-1701428400-1701432000@graspcancer.org
SUMMARY:GRASP Training I
DESCRIPTION:Join us for a training session so that you can be prepared for your upcoming event. Whether joining as a GRASP scientist\, poster author\, mentor\, or patient advocate\, these sessions will help you understand your respective role.
URL:https://graspcancer.org/event/grasp-training-i/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231110T130000
DTEND;TZID=America/New_York:20231110T140000
DTSTAMP:20260502T125335
CREATED:20251126T133237Z
LAST-MODIFIED:20251126T133237Z
UID:10000112-1699621200-1699624800@graspcancer.org
SUMMARY:Advanced Breast Cancer 7th International Consensus Conference
DESCRIPTION:The Advanced Breast Cancer 7th International Consensus Conference (ABC7) will take place Nov 9-11\, 2023. The ABC Conference has established itself as a major international conference for advanced breast cancer\, and a forum for sharing best clinical practices\, inform on the latest scientific updates in the field and\, continue\, over the editions\, advancing the goal of improving outcomes for all patients with advanced breast cancer. GRASP is partnering with the ABC Global Alliance to offer our signature Poster Walkthroughs *in-person* on Fri Nov 10 from 1-2 pm local time during the scheduled lunch and poster session. You must be attending the conference in-person in Lisbon\, Portugal to participate.\nGRASP brings scientists and patient advocates together for a personalized discussion about scientific posters. Less like a presentation\, and more like a conversation\, advocates are encouraged to share their experiences as people living with or caring for someone with this disease. GRASP scientists serve as “interpreters” using their expertise to effectively communicate complex scientific concepts to a general audience.\nGRASP REGISTRATION CLOSED
URL:https://graspcancer.org/event/advanced-breast-cancer-7th-international-consensus-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231005T100000
DTEND;TZID=America/New_York:20231005T193000
DTSTAMP:20260502T125335
CREATED:20251126T133238Z
LAST-MODIFIED:20251126T133238Z
UID:10000110-1696500000-1696534200@graspcancer.org
SUMMARY:International Invasive Lobular Breast Cancer (ILC) Symposium 2023
DESCRIPTION:The 2023 International Invasive Lobular Breast Cancer (ILC) Symposium will be held on September 28-30\, 2023 in Pittsburgh\, PA. This year’s ILC Symposium will be held as a hybrid conference with both in-person events and live web streaming. This international breast cancer symposium will connect research scientists\, clinical oncologists\, trainees\, fellows\, and breast cancer patient advocates to discuss various topics in primary and metastatic invasive lobular breast cancer (ILC). ILC is the second most common “special subtype” of breast cancer\, but our understanding of its unique biology is still emerging.\nOngoing collaborations on the unmet clinical need for people diagnosed and treated each year for ILC is critical for research. GRASP is partnering with the ILC Symposium to bring our signature program of Poster Walkthroughs which will be held virtually after the conference on Oct 5\, 2023. Registration for the ILC Symposium is $25 for patient advocates.\nGRASP REGISTRATION CLOSED
URL:https://graspcancer.org/event/international-invasive-lobular-breast-cancer-ilc-symposium-2023/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230830T170000
DTEND;TZID=America/New_York:20230830T200000
DTSTAMP:20260502T125335
CREATED:20251126T133238Z
LAST-MODIFIED:20251126T133238Z
UID:10000115-1693414800-1693425600@graspcancer.org
SUMMARY:MBC Research Conference (MBCRC23)
DESCRIPTION:The Metastatic Breast Cancer Research Conference (MBCRC23) will take place Aug 30 – Sept 1st\, 2023. MBCRC23 is an annual meeting sponsored by Theresa’s Research Foundation\, Baylor College of Medicine\, and Huntsman Cancer Institute. MBCRC is uniquely focused on metastatic breast cancer which distinguishes it from other breast cancer-centered conferences. GRASP is one of the official advocacy programs of MBCRC23 and will hold Poster Walkthroughs *in-person* on Aug 30. Registration for the MBCRC conference is free!\nGRASP brings scientists and patient advocates together for a personalized discussion about scientific posters. Less like a presentation\, and more like a conversation\, advocates are encouraged to share their experiences as people living with or caring for someone with this disease. GRASP scientists serve as “interpreters” using their expertise to effectively communicate complex scientific concepts to a general audience.\nGRASP REGISTRATION CLOSED\nThank you to our sponsors:
URL:https://graspcancer.org/event/mbc-research-conference-mbcrc23/
END:VEVENT
END:VCALENDAR